Overcoming Cancer Care Disparities: Opportunities for Health Care Providers

Program Description
Inequities exist in cancer incidence, outcomes, and mortality. As more than half of Americans belong to a minority group, an understanding of these disparities is essential for health care providers, including pharmacists. This activity will examine potential biases in cancer health equity, the impact on overall quality of care, and barriers seen in practice. Additionally, faculty experts will bring awareness to the specific roles of each member of the health care team in addressing these disparities.

Target audience: Oncology pharmacists

Type of activity: Application
Release date: December 3, 2021
Expiration date: December 3, 2022

Time to complete activity: 1.0 hour
Fee: Free

Educational Objectives

At the completion of this activity, participants will be able to:

• Examine health care disparities within cancer care
• Characterize perspectives of nurses, pharmacists, and physicians in cancer care disparities
• Explore solutions to cancer care disparities within the multidisciplinary health care team

Pharmacy Times Continuing Education™ is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education. This activity is approved for 1.0 contact hour (0.10 CEU) under the ACPE universal activity number 0290-0000-21-423-H01-P. The activity is available for CE credit through December 3, 2022.

Instructions for Completing the Activity and Receiving CPE Credit

To receive CPE credit, participants must complete the pretest, view the activity in its entirety, complete the posttest, and complete the online activity evaluation. After successful completion of the online activity evaluation, you can submit your credit to CPE Monitor. You may view your credit within 48 hours at www.mycpemonitor.net. All participants must request credit before the activity expiration date. CE credit will not be issued after this date.

Disclosures

Faculty

Maurice Alexander, PharmD, BCOP, CPP, has the following relevant financial relationships with commercial interests to disclose:

Advisory Board: Merck & Co., Omeros, EUSA Pharma, AcelRx

Pharmacy Times Continuing Education™ Planning Staff—Jim Palatine, RPh, MBA; Amy Seung, PharmD, BCOP, FHOPA; Meg Taylor, PharmD, CPP; Crissy Wilson; Susan Pordon; Brianna Winters; and Chloe Taccetta have no relevant financial relationships with commercial interests to disclose.

Anonymous peer reviewers were used as part of content validation and conflict resolution. The peer reviewers have no relevant financial relationships with commercial interests to disclose.

Educational Disclaimer
CPE activities are offered solely for educational purposes and do not constitute any form of professional advice or referral. Discussions concerning drugs, dosages, and procedures may reflect the clinical experience of the author(s) or they may be derived from the professional literature or other sources and may suggest uses that are investigational in nature and not approved labeling or indications. Participants are encouraged to refer to primary references or full prescribing information resources.

For questions about this internet CPE activity, please contact:
[email protected]
Privacy Policy and Terms of Use Information:
www.pharmacytimes.org/terms